XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net income $ 498 $ 509
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:    
Depreciation and amortization 42 40
Deferred income taxes, net (9) 25
Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gain/loss on other investments (12) (11)
Provisions for credit losses and legal and regulatory matters, net 7 21
Share-based compensation expense 90 81
Unrealized gain on company-owned life insurance policies, net of expenses (87) (48)
Other (8) (10)
Net change in:    
Collateralized agreements, net of collateralized financings 143 97
Loans (provided to) financial advisors, net of repayments (54) 25
Brokerage client receivables and other receivables, net 304 477
Trading instruments, net 194 127
Derivative instruments, net (166) (18)
Other assets (40) 8
Brokerage client payables and other payables 161 (3,882)
Accrued compensation, commissions and benefits (423) (511)
Purchases and originations of loans held for sale, net of proceeds from sales of securitizations and loans held for sale (97) (66)
Net cash provided by/(used in) operating activities 543 (3,136) Close
Cash flows from investing activities:    
Increase in bank loans, net (405) (826)
Proceeds from sales of loans held for investment 76 45
Purchases of available-for-sale securities (51) (153)
Available-for-sale securities maturations, repayments and redemptions 295 326
Additions to property and equipment (50) (27)
Investment in solar tax credit equity investment (15) 0
Other investing activities, net (26) (31)
Net cash used in investing activities (176) (666) Close
Cash flows from financing activities:    
Increase in bank deposits 1,194 622
Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements (199) (189)
Dividends on common and preferred stock (97) (81)
Exercise of stock options and employee stock purchases 10 11
Proceeds from Federal Home Loan Bank advances 750 650
Repayments of Federal Home Loan Bank advances and other borrowed funds (750) (791)
Other financing, net (1) (1)
Net cash provided by financing activities 907 221 Close
Currency adjustment:    
Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes 115 215 Close
Net increase/(decrease) in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash 1,389 (3,366) Close
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year 12,548 14,659
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period 13,937 11,293
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash    
Cash and cash equivalents 10,206 6,177
Cash and cash equivalents segregated for regulatory purposes and restricted cash 3,731 5,116
Total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period 13,937 11,293
Supplemental disclosures of cash flow information:    
Cash paid for interest 499 216
Cash paid for income taxes, net 24 13
Cash outflows for lease liabilities 30 31
Non-cash right-of-use assets recorded for new and modified leases $ 17 $ 13